FinancialContent is the trusted provider of stock market information to the media industry.
Latest News about Harvoni
With $36.7B In Cash, Bank of America Expects Gilead To Shop For Complements To Drug Pipeline
February 07, 2018
Gilead Defends Hepatitis C Treatments On Reports Of Side Effects
January 26, 2017
Orphan Drugs Among 2015's Top 10 Best-Selling Medications
January 18, 2017
Gilead Responds To CMS Blog Highlighting High Cost Of Harvoni: Most Payers Receive Substantial Discounts Off The List Price
November 14, 2016
Gilead Sciences Price Target Trimmed Following A Sobering Q3
November 02, 2016
Gilead Vs. Merck: What To Know
March 07, 2016
Will Merck Encroach On Gilead's Harvoni Territory?
February 23, 2016
Gilead Trounces Hep C Estimates; Harvoni International Footprint Nearly Equals U.S.
February 02, 2016
Massachusetts Attorney General To Gilead Sciences: Cost Of Harvoni & Sovaldi Drugs 'May Constitute An Unfair Trade Practice In Violation Of Massachusetts Law'
January 27, 2016
High Drug Prices Put Gilead Under Fire From Senate Committee
December 02, 2015
Keep An Eye On These 8 After-Hours Movers
July 07, 2015
from Stocks to Watch
Gilead Soothes Price War Worry With Q1 Results
May 01, 2015
What's Wall Street Been Saying About Gilead Lately?
April 29, 2015
Gilead Shares Tumble On Drug Warning; Baird Says Buy
March 23, 2015
A Look At 3 Biotech Stocks With Upside Potential
January 12, 2015